Neil Stahl
EVP Research and Development · REGENERON PHARMACEUTICALS, INC.
Individual
- 2024
- Dec 18, 2024
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Neil Stahl files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christine A. Poon - $4.25M in REGN purchases and sales in the last 12 months
- Marion McCourt - $2.00M in REGN purchases and sales in the last 12 months
- Huda Y. Zoghbi - $1.92M in REGN purchases and sales in the last 12 months
- Jason Pitofsky - $1.87M in REGN purchases and sales in the last 12 months
- Kathryn Guarini - $660K in REGN purchases and sales in the last 12 months
- Bonnie L. Bassler - $570K in REGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Neil Stahl?
Neil Stahl is a corporate insider, tracked as EVP Research and Development of REGENERON PHARMACEUTICALS, INC. (REGN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Neil Stahl last file a Form 4?
The most recent primary Form 4 on record is dated 18 December 2024, one of 2 filings going back to 2024.
